Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
Chisa Nakashima, Shigeto Yanagihara, Atsushi Otsuka
Allergology International (2021) Vol. 71, Iss. 1, pp. 40-46
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 175
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
I‐Hsin Huang, Yi‐Teng Hung, Po‐Chien Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 125
JAK-STAT pathway inhibitors in dermatology
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 5, pp. 656-677
Open Access | Times Cited: 41
The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
Aikaterini Tsiogka, Maria Kyriazopoulou, George Kontochristopoulos, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4431-4431
Open Access | Times Cited: 52
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
Fabrizio Martora, Massimiliano Scalvenzi, Angelo Ruggiero, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 801-801
Open Access | Times Cited: 34
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Svenja Müller, Claudia Zeidler, Sonja Ständer
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 1, pp. 15-33
Open Access | Times Cited: 24
Filaggrin and beyond
Nicholas Stefanovic, Alan D. Irvine
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 2, pp. 187-195
Open Access | Times Cited: 23
EuroGuiderm guideline on lichen sclerosus—Treatment of lichen sclerosus
Gudula Kirtschig, Maria Kinberger, Alexander Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 10, pp. 1874-1909
Closed Access | Times Cited: 9
Evodiae Fructus extract suppresses inflammatory response in HaCaT cells and improves house dust mite-induced atopic dermatitis in NC/Nga mice
Seong Eun Jin, Chang‐Seob Seo, Woo‐Young Jeon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Jonathan I. Silverberg, Melinda Gooderham, Amy S. Paller, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 485-496
Open Access | Times Cited: 6
Role of antioxidants supplementation in the treatment of atopic dermatitis: a critical narrative review
Edoardo De Simoni, Matteo Candelora, Sara Belleggia, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 6
Ozonated Sunflower Oil (OSO) Alleviates Inflammatory Responses in Oxazolone-Induced Atopic Dermatitis (AD)-Like Mice and LPS-Treated RAW 264.7 Cells
Su Young Kim, Jung Ok Lee, Sue Lee, et al.
Journal of Microbiology and Biotechnology (2024) Vol. 34, Iss. 4, pp. 765-773
Open Access | Times Cited: 5
NOX4-mediated astrocyte ferroptosis in Alzheimer’s disease
Yasenjiang Maimaiti, Ting Su, Zhanying Zhang, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
The evolving therapeutic landscape in atopic dermatitis
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
κ-Carrageenan tetrasaccharide ameliorates particulate matter-induced defects in skin hydration of human keratinocytes cells and skin barrier disorders
Chun‐Hua Zhu, Tao Hong, Hebin Li, et al.
International Journal of Biological Macromolecules (2025), pp. 140395-140395
Closed Access
Corydalis Tuber Extract Alleviates Atopic Dermatitis: Transcriptomics-Based Mechanism Prediction and In Vitro/In Vivo Studies
Seong Eun Jin, Chang‐Seob Seo, Woo‐Young Jeon, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1291-1291
Open Access
Predictive Factors for Poor Responders to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Real-World Analysis
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Efficacy and safety of systemic targeted therapies for atopic dermatitis in children: A systematic review and meta-analysis
Norio Kawamoto, Hiroki Murai, Kazutaka Nogami, et al.
Allergology International (2025)
Open Access
The future of topical JAK inhibitors in the treatment of atopic dermatitis
Joanna Mazgaj, Magdalena Kotewicz, Andrzej Jaworek, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Effectiveness of Tralokinumab for Different Anatomical Sites and Clinical Signs in Atopic Dermatitis: A 36-Week Real-World Study
Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis (2025)
Closed Access
Real-World Effectiveness and Safety of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: A 16-Week Study in Japan
Teppei Hagino, Akihiko Uchiyama, M Onda, et al.
Dermatitis (2025)
Closed Access
Comparative efficacy and safety of dupilumab versus newly approved biologics and JAKi in pediatric atopic dermatitis: A systematic review and network meta-analysis
Qun Liao, Hong Pan, Yixin Guo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319400-e0319400
Open Access
Biocompatibility and Therapeutic Efficacy of Crosslinked Hydrogel Filled 3D-Printed Nerve Conduit for Sacral Nerve Injury Repair
Jiajia Lu, Yongchuan Li, Jiao Cai, et al.
Biomaterials (2025) Vol. 320, pp. 123230-123230
Closed Access
Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
Spandana Rajendra Kopalli, Venkata Prakash Annamneedi, Sushruta Koppula
Molecules (2022) Vol. 27, Iss. 14, pp. 4660-4660
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top